HOME >> BIOLOGY >> NEWS
Antimicrobial resistance poses increasing problem for growers

St. Paul, MN (August 23, 2001) An apple a day may keep the doctor away but apples themselves are often the victims of disease. In the past, growers have used antimicrobial compounds (or antibiotics as theyre more commonly known) to control fire blight, a common bacterial disease plaguing apples. But antimicrobial compounds are becoming less effective as microorganisms develop resistance to them. In fact, antimicrobial resistance is becoming an increasing problem for growers of other crops as well, and on August 29, the worlds largest group of plant health scientists will meet to discuss the problem of antimicrobial resistance in agriculture.

Antimicrobial agents play an important role in the control of plant diseases, both in the field and after harvesting states Paul Lewis, a plant health scientist, and organizer of the symposium planned for the end of August. Adds Lewis, Apples are a good example since antibiotics are critical for controlling fire blight disease and obtaining an acceptable harvest. However, apple and pear growers are really struggling with the effects of antibiotic resistance.

Since antimicrobial resistance has implications not only for the agricultural community, but the clinical and veterinary communities as well, Lewis has invited experts from these scientific disciplines to share their experience. He hopes their knowledge of the subject will provide new insights for plant disease scientists hoping to uncover alternative methods to fight diseases that are now being controlled with antimicrobial compounds. States Lewis, Its critical that we examine methods to prevent and/or manage antimicrobial resistance if we are to continue to receive the substantial benefits these agents offer. This symposium is designed to help us begin to do just that.


'"/>

Contact: Cindy Ash
cash@scisoc.org
651-454-7250
American Phytopathological Society
24-Aug-2001


Page: 1

Related biology news :

1. Antimicrobial peptides: new weapons to fight infection
2. Nabi reports successful reduction in S. aureus bacteremias at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
3. Antimicrobial Resistance: Issues And Options
4. Enzymes "Magic" May Hold Key to Anticancer and Antimicrobial Drugs
5. Master of antimalarial resistance
6. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
7. Evolvability could be a driving force in drug resistance
8. Insecticide resistance: A constraint on evolutionary change
9. New drug shows promise against Gleevec resistance in mice
10. New milestones on the path to conquering HIV drug resistance (AIDS)
11. Study investigates breast cancer resistance to tamoxifen and possible way to reverse it

Post Your Comments:
(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
(Date:6/23/2015)... 2015   Valencell, a leader in ... a recent study that illustrates its PerformTek biometric ... activity. In a study conducted at Valencell,s Biometric ... the Apple Watch against a chest strap – ... activity. The study demonstrated that Valencell,s biometric technology ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... NEW YORK , July 3, 2015  Pomerantz ... filed against Puma Biotechnology, Inc. ("Puma" or the "Company")(NYSE: ... class action, filed in United States District Court, Central ... under 15-cv-00865, is on behalf of a class consisting ... between July 23, 2014 and May 13, 2015 inclusive ...
(Date:7/2/2015)... GLASGOW, Scotland , July 2, 2015 ...   Bio-tech procurement company Amici Procurement has ... IOM) to help it move to Office 365. ... Procurement provides small to medium-sized companies in the ... with all aspects of the purchasing cycle to help ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
Breaking Biology Technology:Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3
Cached News: